Matthew Reaney

Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis

Gil Yosipovitch, Matthew Reaney, Vera Mastey et al. · British Journal of Dermatology · 2019 · 349 citations · Full text

Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes

Michaëla Diamant, Michael A. Nauck, Rimma M. Shaginian et al. · Diabetes Care · 2014 · 220 citations

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

John A. Spertus, Jennifer Fine, Perry Elliott et al. · The Lancet · 2021 · 202 citations

Cardiomyopathy, Health Status Analysis, Cardiovascular Disease +4

Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT)

David M. Pariser, Eric L. Simpson, Abhijit Gadkari et al. · Current Medical Research and Opinion · 2019 · 128 citations · Full text

Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation

Andrew Briggs, D Wild, Michael Lees et al. · Health and Quality of Life Outcomes · 2008 · 118 citations · Full text